A randomized phase II study of cediranib (CED) alone versus CED plus dasatinib (DAS) in patients (pts) with castration-resistant prostate cancer (CRPC). Phase II trial of intravenous carboplatin (C), ...
A biopsy is the only test that can confirm a cancer diagnosis. However, before doctors conduct a biopsy, they may take a person’s medical history, perform a physical exam, and order various imaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback